THIABENDAZOLE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for thiabendazole and what is the scope of patent protection?
Thiabendazole
is the generic ingredient in one branded drug marketed by Merck Sharp Dohme and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for thiabendazole.
Summary for THIABENDAZOLE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 144 |
| Clinical Trials: | 1 |
| Patent Applications: | 6,173 |
| DailyMed Link: | THIABENDAZOLE at DailyMed |
Recent Clinical Trials for THIABENDAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rigshospitalet, Denmark | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for THIABENDAZOLE
US Patents and Regulatory Information for THIABENDAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | MINTEZOL | thiabendazole | TABLET, CHEWABLE;ORAL | 016096-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | MINTEZOL | thiabendazole | SUSPENSION;ORAL | 016097-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
